Home   Search   Browse   Statistics   User guide   FAQs   Post question   Download   Process data  
Search results for the GEO ID: GSE31652
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM785971
GPL571
1207_150 mg_Week 0 Patient: 1207, Dosage: 150 mg, Time: Week 0 dosage: Dosage: 150 mg patient: Patient: 1207 time: Time: Week 0 1207_v2_16.CEL
GSM785972
GPL571
1207_150 mg_Week 2 Patient: 1207, Dosage: 150 mg, Time: Week 2 dosage: Dosage: 150 mg patient: Patient: 1207 time: Time: Week 2 1207_v7_17.CEL
GSM785973
GPL571
1208_150 mg_Week 0 Patient: 1208, Dosage: 150 mg, Time: Week 0 dosage: Dosage: 150 mg patient: Patient: 1208 time: Time: Week 0 1208_v2_19.CEL
GSM785974
GPL571
1208_150 mg_Week 2 Patient: 1208, Dosage: 150 mg, Time: Week 2 dosage: Dosage: 150 mg patient: Patient: 1208 time: Time: Week 2 1208_v7_20.CEL
GSM785975
GPL571
1209_150 mg_Week 0 Patient: 1209, Dosage: 150 mg, Time: Week 0 dosage: Dosage: 150 mg patient: Patient: 1209 time: Time: Week 0 1209_v2_22.CEL
GSM785976
GPL571
1209_150 mg_Week 2 Patient: 1209, Dosage: 150 mg, Time: Week 2 dosage: Dosage: 150 mg patient: Patient: 1209 time: Time: Week 2 1209_v7_23.CEL
GSM785977
GPL571
1610_150 mg_Week 0 Patient: 1610, Dosage: 150 mg, Time: Week 0 dosage: Dosage: 150 mg patient: Patient: 1610 time: Time: Week 0 1610_v2_108.CEL
GSM785978
GPL571
1610_150 mg_Week 2 Patient: 1610, Dosage: 150 mg, Time: Week 2 dosage: Dosage: 150 mg patient: Patient: 1610 time: Time: Week 2 1610_v7_109.CEL
GSM785979
GPL571
1611_150 mg_Week 0 Patient: 1611, Dosage: 150 mg, Time: Week 0 dosage: Dosage: 150 mg patient: Patient: 1611 time: Time: Week 0 1611_v2_111.CEL
GSM785980
GPL571
1615_150 mg_Week 0 Patient: 1615, Dosage: 150 mg, Time: Week 0 dosage: Dosage: 150 mg patient: Patient: 1615 time: Time: Week 0 1615_v2_123.CEL
GSM785981
GPL571
1615_150 mg_Week 2 Patient: 1615, Dosage: 150 mg, Time: Week 2 dosage: Dosage: 150 mg patient: Patient: 1615 time: Time: Week 2 1615_v7_124.CEL
GSM785982
GPL571
1710_150 mg_Week 0 Patient: 1710, Dosage: 150 mg, Time: Week 0 dosage: Dosage: 150 mg patient: Patient: 1710 time: Time: Week 0 1710_v2_79.CEL
GSM785983
GPL571
1710_150 mg_Week 2 Patient: 1710, Dosage: 150 mg, Time: Week 2 dosage: Dosage: 150 mg patient: Patient: 1710 time: Time: Week 2 1710_v7_80.CEL
GSM785984
GPL571
1803_150 mg_Week 0 Patient: 1803, Dosage: 150 mg, Time: Week 0 dosage: Dosage: 150 mg patient: Patient: 1803 time: Time: Week 0 1803_v2_129.CEL
GSM785985
GPL571
1108_Placebo_Week 0 Patient: 1108, Dosage: Placebo, Time: Week 0 dosage: Dosage: Placebo patient: Patient: 1108 time: Time: Week 0 1108_v2_7.CEL
GSM785986
GPL571
1108_Placebo_Week 2 Patient: 1108, Dosage: Placebo, Time: Week 2 dosage: Dosage: Placebo patient: Patient: 1108 time: Time: Week 2 1108_v7_8.CEL
GSM785987
GPL571
1304_Placebo_Week 0 Patient: 1304, Dosage: Placebo, Time: Week 0 dosage: Dosage: Placebo patient: Patient: 1304 time: Time: Week 0 1304_v2_31.CEL
GSM785988
GPL571
1405_Placebo_Week 0 Patient: 1405, Dosage: Placebo, Time: Week 0 dosage: Dosage: Placebo patient: Patient: 1405 time: Time: Week 0 1405_v2_46.CEL
GSM785989
GPL571
1405_Placebo_Week 2 Patient: 1405, Dosage: Placebo, Time: Week 2 dosage: Dosage: Placebo patient: Patient: 1405 time: Time: Week 2 1405_v7_47.CEL
GSM785990
GPL571
1503_Placebo_Week 0 Patient: 1503, Dosage: Placebo, Time: Week 0 dosage: Dosage: Placebo patient: Patient: 1503 time: Time: Week 0 1503_v2_55.CEL
GSM785991
GPL571
1503_Placebo_Week 2 Patient: 1503, Dosage: Placebo, Time: Week 2 dosage: Dosage: Placebo patient: Patient: 1503 time: Time: Week 2 1503_v7_56.CEL
GSM785992
GPL571
1507_Placebo_Week 0 Patient: 1507, Dosage: Placebo, Time: Week 0 dosage: Dosage: Placebo patient: Patient: 1507 time: Time: Week 0 1507_v2_64.CEL
GSM785993
GPL571
1507_Placebo_Week 2 Patient: 1507, Dosage: Placebo, Time: Week 2 dosage: Dosage: Placebo patient: Patient: 1507 time: Time: Week 2 1507_v7_65.CEL
GSM785994
GPL571
1613_Placebo_Week 0 Patient: 1613, Dosage: Placebo, Time: Week 0 dosage: Dosage: Placebo patient: Patient: 1613 time: Time: Week 0 1613_v2_117.CEL
GSM785995
GPL571
1613_Placebo_Week 2 Patient: 1613, Dosage: Placebo, Time: Week 2 dosage: Dosage: Placebo patient: Patient: 1613 time: Time: Week 2 1613_v7_118.CEL
GSM785996
GPL571
1614_Placebo_Week 0 Patient: 1614, Dosage: Placebo, Time: Week 0 dosage: Dosage: Placebo patient: Patient: 1614 time: Time: Week 0 1614_v2_120.CEL
GSM785997
GPL571
1614_Placebo_Week 2 Patient: 1614, Dosage: Placebo, Time: Week 2 dosage: Dosage: Placebo patient: Patient: 1614 time: Time: Week 2 1614_v7_121.CEL
GSM785998
GPL571
1702_Placebo_Week 0 Patient: 1702, Dosage: Placebo, Time: Week 0 dosage: Dosage: Placebo patient: Patient: 1702 time: Time: Week 0 1702_v2_67.CEL
GSM785999
GPL571
1702_Placebo_Week 2 Patient: 1702, Dosage: Placebo, Time: Week 2 dosage: Dosage: Placebo patient: Patient: 1702 time: Time: Week 2 1702_v7_68.CEL
GSM786000
GPL571
1704_Placebo_Week 2 Patient: 1704, Dosage: Placebo, Time: Week 2 dosage: Dosage: Placebo patient: Patient: 1704 time: Time: Week 2 1704_v7_71.CEL
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes